181 related articles for article (PubMed ID: 26201895)
1. MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3.
Han LP; Fu T; Lin Y; Miao JL; Jiang QF
Tumour Biol; 2016 Jan; 37(1):291-8. PubMed ID: 26201895
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2.
Xie J; Yu F; Li D; Zhu X; Zhang X; Lv Z
Tumour Biol; 2016 Jan; 37(1):1197-204. PubMed ID: 26282001
[TBL] [Abstract][Full Text] [Related]
3. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
Zhang X; Zhang X; Yu B; Hu R; Hao L
Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M
Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132
[TBL] [Abstract][Full Text] [Related]
5. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.
Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M
Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569
[TBL] [Abstract][Full Text] [Related]
6. miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression.
Sui C; Meng F; Li Y; Jiang Y
J Transl Med; 2015 Apr; 13():132. PubMed ID: 25927928
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel inhibits the proliferation of non-small-cell lung cancer cells via upregulation of microRNA-7 expression.
He X; Li C; Wu X; Yang G
Int J Clin Exp Pathol; 2015; 8(8):9072-80. PubMed ID: 26464649
[TBL] [Abstract][Full Text] [Related]
8. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J
Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099
[TBL] [Abstract][Full Text] [Related]
9. miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.
Wang F; Lou JF; Cao Y; Shi XH; Wang P; Xu J; Xie EF; Xu T; Sun RH; Rao JY; Huang PW; Pan SY; Wang H
Exp Mol Med; 2015 May; 47(5):e162. PubMed ID: 25952770
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2.
Zhao Z; Liu J; Wang C; Wang Y; Jiang Y; Guo M
Int J Clin Exp Pathol; 2014; 7(11):7726-34. PubMed ID: 25550809
[TBL] [Abstract][Full Text] [Related]
11. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.
Rao C; Miao X; Zhao G; Zhang C; Shen H; Dong C; Yang M
Biomed Pharmacother; 2019 Jun; 114():108662. PubMed ID: 30999114
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-99b inhibits NSCLC cell invasion and migration by directly targeting NIPBL.
Xu JX; Liu CM; Ma CP
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1890-1898. PubMed ID: 33660799
[TBL] [Abstract][Full Text] [Related]
14. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer.
Yu S; Qin X; Chen T; Zhou L; Xu X; Feng J
Anticancer Drugs; 2017 Sep; 28(8):852-860. PubMed ID: 28723865
[TBL] [Abstract][Full Text] [Related]
16. MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19.
Shan N; Shen L; Wang J; He D; Duan C
Biochem Biophys Res Commun; 2015 Jan; 456(1):385-91. PubMed ID: 25475731
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma.
Huang B; Li H; Huang L; Luo C; Zhang Y
J Surg Res; 2015 Feb; 193(2):718-23. PubMed ID: 25439221
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer.
Li Q; Wu X; Guo L; Shi J; Li J
FEBS Open Bio; 2019 Nov; 9(11):1983-1993. PubMed ID: 31587474
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-377 inhibits non-small-cell lung cancer through targeting AEG-1.
Meng F; Zhang L; Shao Y; Ma Q; Lv H
Int J Clin Exp Pathol; 2015; 8(11):13853-63. PubMed ID: 26823698
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3.
Koo KH; Kwon H
Cell Death Dis; 2018 Jan; 9(2):77. PubMed ID: 29362401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]